LABCORP HOLDINGS INC. Financial Summary

Quick Answer

LABCORP HOLDINGS INC. reported Total Revenue of $13.95 billion for fiscal year 2025.

LABCORP HOLDINGS INC. — Key Financials by Year

Metric 2025 2024 2023 2022 2021 2020
Total Revenue $13.95B
+7.2%
$13.01B
+7.0%
$12.16B
+2.5%
$11.86B
-9.7%
$13.14B
-6.0%
$13.98B
+21.0%
Net Income $876.50M
+17.5%
$746.00M
+78.5%
$418.00M
-67.3%
$1.28B
-46.2%
$2.38B
+52.8%
$1.56B
+88.9%
Diluted EPS $10.46
+18.3%
$8.84
+85.3%
$4.77
-65.9%
$13.97
-42.7%
$24.39
Total Assets $18.39B
+0.1%
$18.38B
+9.9%
$16.73B
-17.0%
$20.16B
-1.1%
$20.39B
+1.6%
$20.07B
+11.2%
Cash and Equivalents $532.30M
-65.0%
$1.52B
+182.9%
$536.80M
+67.4%
$320.60M
-78.2%
$1.47B
+11.5%
$1.32B
+291.3%
Long-Term Debt $5.08B
-4.6%
$5.33B
+31.5%
$4.05B
-19.5%
$5.04B
-7.0%
$5.42B
-0.0%
$5.42B
-6.4%
Stockholders Equity $8.62B
+7.0%
$8.05B
+2.3%
$7.88B
-22.0%
$10.10B
-1.7%
$10.27B
+8.9%
$9.44B
+23.5%
Operating Income $1.38B
+27.4%
$1.09B
+49.8%
$725.60M
-49.5%
$1.44B
-52.9%
$3.05B
+24.7%
$2.45B
+83.8%
Gross Profit $4.01B
+10.7%
$3.62B
+7.7%
$3.36B
-9.3%
$3.71B
-25.7%
$4.99B
+0.8%
$4.95B
+52.3%
Shares Outstanding 82.20M
-1.4%
83.40M
-0.6%
83.90M
-4.9%
88.20M
-5.3%
93.10M

Most Recent Quarter

Metric Quarter Ending Value YoY QoQ
Total Revenue September 30, 2025 $3.56B +8.6% +1.0%
Net Income September 30, 2025 $261.10M +54.2% +9.8%
Diluted EPS September 30, 2025 $3.12 +56.0% +9.9%
Total Assets September 30, 2025 $18.26B -1.9% +1.1%
Cash and Equivalents September 30, 2025 $598.10M -60.6% -7.6%
Long-Term Debt September 30, 2025 $5.08B -5.0% +0.1%
Stockholders Equity September 30, 2025 $8.70B +6.4% +2.6%
Operating Income September 30, 2025 $396.60M +56.1% +0.5%
Gross Profit September 30, 2025 $1.03B +13.3% -2.0%
Shares Outstanding September 30, 2025 83.00M -0.8% +0.1%
  • LABCORP HOLDINGS INC. reported Total Revenue of $13.95 billion for fiscal year 2025.
  • LABCORP HOLDINGS INC. showed an increase of +7.2% in Total Revenue compared to the prior fiscal year.
  • LABCORP HOLDINGS INC. reported Net Income of $876.50 million for fiscal year 2025.
  • LABCORP HOLDINGS INC. showed an increase of +17.5% in Net Income compared to the prior fiscal year.
  • LABCORP HOLDINGS INC. reported Diluted EPS of $10.46 per share for fiscal year 2025.
  • LABCORP HOLDINGS INC. showed an increase of +18.3% in Diluted EPS compared to the prior fiscal year.
  • LABCORP HOLDINGS INC. reported Total Assets of $18.39 billion for fiscal year 2025.
  • LABCORP HOLDINGS INC. showed an increase of +0.1% in Total Assets compared to the prior fiscal year.
  • LABCORP HOLDINGS INC. reported Cash and Equivalents of $532.30 million for fiscal year 2025.
  • LABCORP HOLDINGS INC. showed a decrease of -65.0% in Cash and Equivalents compared to the prior fiscal year.
  • LABCORP HOLDINGS INC. reported Long-Term Debt of $5.08 billion for fiscal year 2025.
  • LABCORP HOLDINGS INC. showed a decrease of -4.6% in Long-Term Debt compared to the prior fiscal year.
  • LABCORP HOLDINGS INC. reported Stockholders Equity of $8.62 billion for fiscal year 2025.
  • LABCORP HOLDINGS INC. showed an increase of +7.0% in Stockholders Equity compared to the prior fiscal year.
  • LABCORP HOLDINGS INC. reported Operating Income of $1.38 billion for fiscal year 2025.
  • LABCORP HOLDINGS INC. showed an increase of +27.4% in Operating Income compared to the prior fiscal year.
  • LABCORP HOLDINGS INC. reported Gross Profit of $4.01 billion for fiscal year 2025.
  • LABCORP HOLDINGS INC. showed an increase of +10.7% in Gross Profit compared to the prior fiscal year.
  • LABCORP HOLDINGS INC. reported Shares Outstanding of 82.20 million shares for fiscal year 2025.
  • LABCORP HOLDINGS INC. showed a decrease of -1.4% in Shares Outstanding compared to the prior fiscal year.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment